agilon health CLO reports tax share withholding

agilon health, inc. reports that Chief Legal Officer Denise Zamore had 37 shares of Common Stock withheld on 2026-08-01 to satisfy income tax withholding and remittance obligations related to net settlement of restricted stock units.

Rhea-AI Filing Summary

agilon health, inc. reports that Chief Legal Officer Denise Zamore had 37 shares of Common Stock withheld on 2026-08-01 to satisfy income tax withholding and remittance obligations related to net settlement of restricted stock units. This is characterized as a tax-withholding disposition and not a sale. Following this transaction, she directly holds 66,075 shares of Common Stock, including restricted stock units.

Insider Trade Summary

Tax Withholding: 37 shares

Tax Withholding 1 txn

Insider Zamore Denise

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1, F2	37	$91.61	$3K

Holdings After Transaction: Common Stock — 66,075 shares (Direct)

Footnotes (2)

1. F1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
2. F2. Includes restricted stock units.

Key Figures

Shares withheld for taxes: 37 shares Per-share value used: 91.6100 per share Post-transaction holdings: 66,075 shares

3 metrics

Shares withheld for taxes 37 shares Common Stock withheld to satisfy income tax obligations on 2026-08-01

Per-share value used 91.6100 per share Value applied to the 37 withheld Common Stock shares

Post-transaction holdings 66,075 shares Directly held agilon health Common Stock after withholding, including RSUs

Key Terms

restricted stock units, net settlement, income tax withholding, remittance obligations

4 terms

restricted stock units financial

"in connection with the net settlement of the restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

net settlement financial

"obligations in connection with the net settlement of the restricted stock units"

income tax withholding financial

"withheld by the issuer to satisfy its income tax withholding and remittance obligations"

remittance obligations financial

"to satisfy its income tax withholding and remittance obligations in connection"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did agilon health (AGL) disclose for Denise Zamore?

agilon health, inc. disclosed that Chief Legal Officer Denise Zamore had 37 shares of Common Stock withheld to cover income tax obligations from net settlement of restricted stock units. The company notes this tax-withholding disposition does not represent a sale of shares.

How many agilon health (AGL) shares were withheld for Denise Zamore’s taxes?

The filing reports that 37 shares of agilon health, inc. Common Stock were withheld to satisfy income tax withholding and remittance obligations associated with net settlement of restricted stock units. This withholding is recorded as a disposition but is explicitly not treated as a sale.

How many agilon health (AGL) shares does Denise Zamore hold after the reported event?

After the tax-withholding disposition, Chief Legal Officer Denise Zamore directly holds 66,075 shares of agilon health, inc. Common Stock. A footnote clarifies that this post-transaction amount includes restricted stock units in addition to other directly held shares.

Was the agilon health (AGL) insider transaction a market sale of shares?

No. The filing states the 37 shares were withheld by agilon health, inc. to satisfy income tax withholding and remittance obligations from restricted stock unit settlement and “does not represent a sale.” It is categorized as a tax-withholding disposition, not an open-market sale.

What role does Denise Zamore hold at agilon health (AGL) in this Form 4 filing?

In this Form 4, Denise Zamore is identified as an officer of agilon health, inc., serving as Chief Legal Officer. The reported transaction reflects shares withheld for her tax obligations arising from the net settlement of restricted stock units granted as part of compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:23 PM Accepted by SEC EDGAR 08/04/2026 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zamore Denise

(Last) (First) (Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OHIO 43082

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2026		F		37(1)	D	$91.61	66,075(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.

2. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)